Kineta to Present at the Oppenheimer 33rd Annual Healthcare

Kineta to Present at the Oppenheimer 33rd Annual Healthcare

SEATTLE, March 08, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel......

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation......

Kineta Appoints Internationally-Renowned Clinical

Kineta Appoints Internationally-Renowned Clinical

SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation......

menu
menu